Primary Total: $52,502,661
Total: $42,538,086
Primary Total: $39,077,134
Total: $4,529,096
Primary Total: $3,734,682
*Treatment of Behavioral Agitation in Alzheimer's Disease, (428327), Univ of California San Diego, $28,438 (adjustment).
*A Multicenter, Open-Label, Study of the Safety and Tolerability of Metrifonate (BAY A 9826) in Patients with Probable Alzheimer's Disease, (428749), Miles Laboratories Inc, $57,427 (adjustment).
Regulation of Neuronal Calcium and Gene Expression by Amyloid Precursor Protein and Cyclic GMP, (428583), French Fdtn For Alzheimer Research Inc, $15,000 (adjustment).
*Effects of Basic Fiberoblast Growth Factor and Methylprednisolone on Experimental Spinal Cord Injury in the Rat, (429661), Kentucky Spinal Cord and Head Injury Trust, $97,456.
*Social Cognition Following Right Hemisphere Stroke, (426015), Neurological Communicative Disorders and Stroke, $104,596 (adjustment).
B-Lymphocyte Receptors for Growth and Maturation Factors, (428058), Allergy and Infectious Diseases, $219,028 (adjustment).
Elder Care Consultation, (429697), Maxwell Street Presbyterian Church, $500.
*Role of Metalloproteinases in Ovarian Function, (429851), Child Health and Human Development, $183,914.
*Physiology and Pathophysiology of the Microcirculation, (428403), Natl Heart Lung and Blood Institute, $859 (adjustment).
Alzheimer's Disease Research Center: Project 2, (433091), Natl Institute on Aging, $14,700 (adjustment).
Alzheimer's Disease Research Center: Project 2, (433385), Natl Institute on Aging, $126,350.
*Alzheimer's Disease Research Center: Project 3, (433386), Natl Institute on Aging, $93,683.
Training for Designated Geriatric Specialist - Department of Mental Health, (429497), Dept for Mental Health/Mental Retardation Services, $10,507.
*Structural Prerequisites for Amyloid Fibrillogenesis, (428443), Natl Institute on Aging, $160,301 (adjustment).
*Alzheimer's Disease Research Center: Biostatics Core B, (433378), Natl Institute on Aging, $89,552.
National Case Management Partnership, (427785), Connecticut Community Care, $3,383 (adjustment).
ElderCare Consultation and Referral Service, (427917), Work Family Elder Directions Inc, $5,330 (adjustment).
Kentucky Long-Term Care Case Management Demonstration Project Evaluation, (429166), KY Cab for Human Resources, $12,075.
The Partnership Group Agreement, (428162), Partnership Group, $241 (adjustment).
*Brain Vasculature on Leukoaraiosis and Cardiac Surgery, (428584), Wake Forest Univ, $24,530 (adjustment).
*Alzheimer's Disease Research Center: Clinical Core C, (433379), Natl Institute on Aging, $328,441.
*Alzheimer's Disease Research Center: Neuopathalogy Core D, (433382), Natl Institute on Aging, $118,254.
*Alzheimer's Disease Research Center: Pilot 2 Administrative Account, (433432), Natl Institute on Aging, $23,247.
*Alzheimer's Disease Research Center: SDTC #1, (433380), Natl Institute on Aging, $59,284.
*Alzheimer's Disease Research Center: Administrative Core, (429759), Natl Institute on Aging, $1,249,791.
*Alzheimer's Disease Research Center: SDTC #1, (433242), Natl Institute on Aging, $5,231 (adjustment).
*Alzheimer's Disease Research Center: SDTC #2, (433241), Natl Institute on Aging, $11,284 (adjustment).
*Alzheimer's Disease Research Center: Cinical Core C, (433085), Natl Institute on Aging, $45,426 (adjustment).
*Alzheimer's Disease Research Center: SDTC #2, (433381), Natl Institute on Aging, $110,962.
*Alzheimer's Disease Research Center: Neuopathalogy Core D, (433090), Natl Institute on Aging, $50,276 (adjustment).
*Ohio Valley Appalachia Regional Geriatric Education Center, (429279), Health Professions Bureau, $319,206.
*Alzheimer's Disease, Dental Amalgams and Mercury, (425673), Natl Institute on Aging, $156,574 (adjustment).
*Alzheimer's Disease Research Center: Project 1, (433384), Natl Institute on Aging, $116,173.
*Calcium Signaling and Neuronal Degeneration, (428930), Neurological Communicative Disorders and Stroke, $78,786 (adjustment). *AB, Free Radicals, Ion-Motive Atpases and Neuronal Death, (428269), Alzheimers Assoc, $89,232 (adjustment).
*Alzheimer's Disease Research Center: Project 1, (433088), Natl Institute on Aging, $14,700 (adjustment).
*Alkaloid Neurotrophic Factor Mimicks: Candidate Therapeutics for Traumatic Brain Injury, (429649), KY Cab for Human Resources, $99,110.
*Calpain and Excitotoxicity in Focal Cerebral Ischemia, (429747), American Health Assistance Fdtn, $15,000.
*Alzheimer's Disease Research Center: Project 2, (433257), Natl Institute on Aging, $6,840 (adjustment).
*Antiphospholipid Antibodies and Stroke, (427702), Henry Ford Hospital for APASS Consortium, $1,100 (adjustment).
*Microtubular Proteolysis in Cerebral Ischemia, (429277), Natl Institute of Neurological Diseases & Stroke, $292,220.
*A Placebo-Controlled Study to Determine the Effects of 500mg, 1000mg, and 2000mg Citicoline in Ischemic Stroke Patients, (428018), Parexel International Co, $51,167 (adjustment).
*Warfarin Antiplatelet Recurrent Stroke Study, (429729), Columbia Univ, $80,650.
*Evaluation of Personality Functioning Following Traumatic Head Injury Using the NEO-PI-R, (429660), Kentucky Spinal Cord and Head Injury Trust, $29,351.
*Mechanisms of Brain Injury and Its Systemic
Sequelae, (433077), Natl Institute of Neurological Diseases & Stroke, $143,518 (adjustment).
*Human Age-Related Changes in Synaptic Density, (428711), Natl Institute on Aging, $146,294 (adjustment).
*A Multicenter, Evaluator-Blind, Three-Arm Study of the Study of the Safety and Efficacy of Bucladesine Sodium Ointment in the Treatment of Stage III Pressure Ulcers in Patients with Spinal Cord Injuries, (460043), Daiichi Pharmaceutical Corp, $2.
*Instrumentation Protocol, (433347), Univ of California San Diego, $30,000.
*A Placebo-Controlled Study of Acetyl-1-Carnitine in Patients with Alzheimer's Disease: A Multi-Center Study, (424813), Sigma Tau Pharmaceuticals, $4,675 (adjustment).
*Alzheimer's Disease Cooperative Study Unit, (426468), Univ of California San Diego, $10,858 (adjustment).
A Multi-Center, Open-Label Study of the Safety and Tolerability of Metrifonate (BAY A 9826) in Patients with Probable Alzheimer's Disease, (433351), Miles Pharmaceuticals, $9,819.
*Selegiline (Deprenyl) Protocol, (426881), Univ of California San Diego, $56,219 (adjustment).
*Selegiline (Deprenyl) Protocol, (433285), Univ of California San Diego, $14,782.
*The Epidemiology of Aging and Alzheimer's Disease, (427730), Natl Institute on Aging, $64,718 (adjustment).
*Independent and Dependent Life in the Elderly, (429841), Natl Institute on Aging, $676,778.
*Alzheimer's Disease Research Center: Pilot 1 Administrative Account, (433431), Natl Institute on Aging, $28,004.
*Zinc B12 and Cognitive Decline in the Elderly, (429027), Natl Institute on Aging, $150,070.
*Alzheimer's Disease Research Center: Information Core E, (433383), Natl Institute on Aging, $71,740.
*Mechanisms of Brain Injury and Its Systemic Sequelae, (433079), Natl Institute of Neurological Diseases & Stroke, $133,101 (adjustment).
*Mechanisms of Brain Injury and Its Systemic Sequelae, (433076), Natl Institute of Neurological Diseases & Stroke, $127,926 (adjustment).
For questions regarding listings, contact Ms. Deborah Davis, director of the Office of Sponsored Projects Administration, 214 Kinkead Hall, 0057, phone 257-8311. (ddavis@pop.uky.edu )
Last Updated: 6/30/03